SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Stock
Equities
6990
CNE1000062J1
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 173.9 HKD | +6.04% |
|
+3.57% | +69.00% |
| 06:58am | Kelun-Biotech's Lung Cancer Drug Advances to Phase 2 Trials in US; Shares Up 8% | MT |
| Apr. 15 | Sichuan Kelun-Biotech Buys Structured Deposits Worth 680 Million Yuan | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 1.16B 161M 1.26B | Sales 2025 * | 1.52B 211M 1.65B | Capitalization | 33.3B 4.62B 36.09B |
|---|---|---|---|---|---|
| Net income 2024 * | -625M -86.63M -677M | Net income 2025 * | -684M -94.81M -741M | EV / Sales 2024 * | 28.2 x |
| Net cash position 2024 * | 575M 79.68M 623M | Net cash position 2025 * | 774M 107M 839M | EV / Sales 2025 * | 21.3 x |
| P/E ratio 2024 * |
-51.2
x | P/E ratio 2025 * |
-47.1
x | Employees | 1,446 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.25% |
More Fundamentals
* Assessed data
More news
| 1 day | +6.04% | ||
| 1 week | +3.57% | ||
| Current month | +3.33% | ||
| 1 month | +21.27% | ||
| 3 months | +109.52% | ||
| 6 months | +109.52% | ||
| Current year | +69.00% |
1 week
157.10
182.20
1 month
129.20182.20
Current year
63.65182.20
1 year
60.60182.20
3 years
60.60182.20
5 years
60.60182.20
10 years
60.60182.20
| Managers | Title | Age | Since |
|---|---|---|---|
Jun You Ge
CEO | Chief Executive Officer | 51 | 21-02-07 |
Ze Jian Zhou
DFI | Director of Finance/CFO | 41 | 22-02-24 |
Xiang Yang Tan
CTO | Chief Tech/Sci/R&D Officer | 61 | 21-07-04 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ge Xin Liu
FOU | Founder | 73 | 16-11-21 |
Yue Dong Li
BRD | Director/Board Member | 47 | 23-02-14 |
Si Chuan Liu
BRD | Director/Board Member | 40 | 16-11-21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-06 | 173.9 | +6.04% | 317 056 |
| 24-05-03 | 164 | -2.26% | 84,900 |
| 24-05-02 | 167.8 | -0.30% | 123,170 |
| 24-04-30 | 168.3 | +0.24% | 233,800 |
| 24-04-29 | 167.9 | -0.06% | 278,600 |
Delayed Quote Hong Kong S.E., May 06, 2024 at 03:59 am EDT
More quotes
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, formerly Sichuan Kelun Biotech Biopharmaceutical Co Ltd, is a China-based company mainly engaged in the research and development, production, and sales of drugs. The Company is mainly engaged in the research and development, production, and sales of biopharmaceuticals, chemical raw materials, and chemical drug formulations. The Company's products are mainly used for the treatment of breast cancer, non-small cell lung cancer, Gastrointestinal cancer and other non tumor diseases.
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
164
HKD
Average target price
184
HKD
Spread / Average Target
+12.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +69.00% | 4.6B | |
| +8.96% | 105B | |
| -1.43% | 104B | |
| +5.27% | 22.94B | |
| -12.15% | 22.34B | |
| -6.50% | 19.25B | |
| -39.98% | 17.08B | |
| -10.04% | 16.96B | |
| +38.61% | 12.63B | |
| +313.59% | 8.49B |
- Stock Market
- Equities
- 6990 Stock